Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q54867176
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241120235922.0 |
008
|
|
|
241120nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q54867176
|
024
|
|
|
‡a
0000-0002-5181-2135
‡2
orcid
|
024
|
|
|
‡a
7407089703
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q54867176
|
100
|
0 |
|
‡a
Wan Lee
‡9
ast
‡9
es
‡9
sl
|
400
|
0 |
|
‡a
Wan Lee
‡c
researcher (ORCID 0000-0002-5181-2135)
‡9
en
|
400
|
0 |
|
‡a
Wan Lee
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A Synthetic Peptide Corresponding to the GLUT4 C-terminal Cytoplasmic Domain Causes Insulin-like Glucose Transport Stimulation and GLUT4 Recruitment in Rat Adipocytes
|
670
|
|
|
‡a
Author's Association of carboxyl esterase with facilitative glucose transporter isoform 4
|
670
|
|
|
‡a
Author's Association of carboxyl esterase with facilitative glucose transporter isoform 4 (GLUT4) intracellular compartments in rat adipocytes and its possible role in insulin-induced GLUT4 recruitment.
|
670
|
|
|
‡a
Author's C1q tumor necrosis factor Alpha -related protein isoform 5 is increased in mitochondrial DNA-depleted myocytes and activates AMP-activated protein kinase
|
670
|
|
|
‡a
Author's C1q tumor necrosis factor α-related protein isoform 5 attenuates palmitate-induced DNA fragmentation in myocytes through an AMPK-dependent mechanism
|
670
|
|
|
‡a
Author's C1qTNF-related protein-6 mediates fatty acid oxidation via the activation of the AMP-activated protein kinase
|
670
|
|
|
‡a
Author's Cadmium induces impaired glucose tolerance in rat by down-regulating GLUT4 expression in adipocytes.
|
670
|
|
|
‡a
Author's Combination gene therapy using multidrug resistance
|
670
|
|
|
‡a
Author's Combination gene therapy using multidrug resistance (MDR1) gene shRNA and herpes simplex virus-thymidine kinase
|
670
|
|
|
‡a
Author's CTRP5 ameliorates palmitate-induced apoptosis and insulin resistance through activation of AMPK and fatty acid oxidation.
|
670
|
|
|
‡a
Author's Dangnyohwan improves glucose utilization and reduces insulin resistance by increasing the adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima Fatty rats.
|
670
|
|
|
‡a
Author's Data for differentially expressed microRNAs in saturated fatty acid palmitate-treated HepG2 cells
|
670
|
|
|
‡a
Author's Data on the decreased expression of FOXO1 by miR-1271 in HepG2 hepatocytes
|
670
|
|
|
‡a
Author's Data on the effect of miR-15b on the expression of INSR in murine C2C12 myocytes
|
670
|
|
|
‡a
Author's Data on the expression and insulin-stimulated phosphorylation of IRS-1 by miR-96 in L6-GLUT4myc myocytes
|
670
|
|
|
‡a
Author's Data on the expression of PEPCK in HepG2 hepatocytes transfected with miR-195.
|
670
|
|
|
‡a
Author's Dataset on the identification of differentially expressed genes by annealing control primer-based PCR in mitochondrial DNA-depleted myocytes.
|
670
|
|
|
‡a
Author's Depletion of mitochondrial DNA causes impaired glucose utilization and insulin resistance in L6 GLUT4myc myocytes.
|
670
|
|
|
‡a
Author's Depletion of mitochondrial DNA up-regulates the expression of MDR1 gene via an increase in mRNA stability.
|
670
|
|
|
‡a
Author's EHD2 interacts with the insulin-responsive glucose transporter (GLUT4) in rat adipocytes and may participate in insulin-induced GLUT4 recruitment.
|
670
|
|
|
‡a
Author's Ets-2 is involved in transcriptional regulation of C1qTNF-related protein 5 in muscle cells
|
670
|
|
|
‡a
Author's Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy.
|
670
|
|
|
‡a
Author's Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people.
|
670
|
|
|
‡a
Author's Glucose transporters and insulin action: some insights into diabetes management.
|
670
|
|
|
‡a
Author's Implications of microRNAs in the pathogenesis of diabetes.
|
670
|
|
|
‡a
Author's Induction of miR-29a by saturated fatty acids impairs insulin signaling and glucose uptake through translational repression of IRS-1 in myocytes.
|
670
|
|
|
‡a
Author's Induction of miR-96 by Dietary Saturated Fatty Acids Exacerbates Hepatic Insulin Resistance through the Suppression of INSR and IRS-1.
|
670
|
|
|
‡a
Author's MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function
|
670
|
|
|
‡a
Author's MicroRNA expression analysis in the liver of high fat diet-induced obese mice
|
670
|
|
|
‡a
Author's MiR-1271 upregulated by saturated fatty acid palmitate provokes impaired insulin signaling by repressing INSR and IRS-1 expression in HepG2 cells
|
670
|
|
|
‡a
Author's MiR-96-5p Induced by Palmitic Acid Suppresses the Myogenic Differentiation of C2C12 Myoblasts by Targeting FHL1
|
670
|
|
|
‡a
Author's Modulation of GLUT4 and GLUT1 recycling by insulin in rat adipocytes: kinetic analysis based on the involvement of multiple intracellular compartments.
|
670
|
|
|
‡a
Author's N-Acetylated Alpha -linked acidic dipeptidase expressed in rat adipocytes is localized in the insulin-responsive glucose transporter (GLUT4) intracellular compartments and involved in the insulin-stimulated GLUT4 recruitment.
|
670
|
|
|
‡a
Author's Obesity-induced miR-15b is linked causally to the development of insulin resistance through the repression of the insulin receptor in hepatocytes.
|
670
|
|
|
‡a
Author's Proteomic analysis of cellular change involved in mitochondria-to-nucleus communication in L6 GLUT4myc myocytes
|
670
|
|
|
‡a
Author's Regulation of the transcriptional activation of CTRP3 in chondrocytes by c-Jun.
|
670
|
|
|
‡a
Author's Saturated fatty acid-induced miR-195 impairs insulin signaling and glycogen metabolism in HepG2 cells.
|
670
|
|
|
‡a
Author's Saturated fatty acids-induced miR-424-5p aggravates insulin resistance via targeting insulin receptor in hepatocytes
|
670
|
|
|
‡a
Author's Sfrp2 is a transcriptional target of SREBP-1 in mouse chondrogenic cells.
|
670
|
|
|
‡a
Author's The hepatocyte glucose-6-phosphatase subcomponent T3: its relationship to GLUT2.
|
670
|
|
|
‡a
Author's The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes
|
670
|
|
|
‡a
Author's The induction of miR-96 by mitochondrial dysfunction causes impaired glycogen synthesis through translational repression of IRS-1 in SK-Hep1 cells.
|
909
|
|
|
‡a
(orcid) 0000000251812135
‡9
1
|
909
|
|
|
‡a
(scopus) 7407089703
‡9
1
|
919
|
|
|
‡a
syntheticpeptidecorrespondingtotheglut4100terminalcytoplasmicdomaincausesinsulinlikeglucosetransportstimulationandglut4recruitmentinratadipocytes
‡A
A Synthetic Peptide Corresponding to the GLUT4 C-terminal Cytoplasmic Domain Causes Insulin-like Glucose Transport Stimulation and GLUT4 Recruitment in Rat Adipocytes
‡9
1
|
919
|
|
|
‡a
associationofcarboxylesterasewithfacilitativeglucosetransporterisoform4
‡A
Association of carboxyl esterase with facilitative glucose transporter isoform 4
‡9
1
|
919
|
|
|
‡a
associationofcarboxylesterasewithfacilitativeglucosetransporterisoform4glut4intracellularcompartmentsinratadipocytesanditspossibleroleininsulininducedglut4recruitment
‡A
Association of carboxyl esterase with facilitative glucose transporter isoform 4 (GLUT4) intracellular compartments in rat adipocytes and its possible role in insulin-induced GLUT4 recruitment.
‡9
1
|
919
|
|
|
‡a
c1qtumornecrosisfactor Alpha relatedproteinisoform5isincreasedinmitochondrialdnadepletedmyocytesandactivatesampactivatedproteinkinase
‡A
C1q tumor necrosis factor Alpha -related protein isoform 5 is increased in mitochondrial DNA-depleted myocytes and activates AMP-activated protein kinase
‡9
1
|
919
|
|
|
‡a
c1qtumornecrosisfactorαrelatedproteinisoform5attenuatespalmitateinduceddnafragmentationinmyocytesthroughanampkdependentmechanism
‡A
C1q tumor necrosis factor α-related protein isoform 5 attenuates palmitate-induced DNA fragmentation in myocytes through an AMPK-dependent mechanism
‡9
1
|
919
|
|
|
‡a
c1qtnfrelatedprotein6mediatesfattyacidoxidationviatheactivationoftheampactivatedproteinkinase
‡A
C1qTNF-related protein-6 mediates fatty acid oxidation via the activation of the AMP-activated protein kinase
‡9
1
|
919
|
|
|
‡a
cadmiuminducesimpairedglucosetoleranceinratbydownregulatingglut4expressioninadipocytes
‡A
Cadmium induces impaired glucose tolerance in rat by down-regulating GLUT4 expression in adipocytes.
‡9
1
|
919
|
|
|
‡a
combinationgenetherapyusingmultidrugresistance
‡A
Combination gene therapy using multidrug resistance
‡9
1
|
919
|
|
|
‡a
combinationgenetherapyusingmultidrugresistancemdr1geneshrnaandherpessimplexvirusthymidinekinase
‡A
Combination gene therapy using multidrug resistance (MDR1) gene shRNA and herpes simplex virus-thymidine kinase
‡9
1
|
919
|
|
|
‡a
ctrp5amelioratespalmitateinducedapoptosisandinsulinresistancethroughactivationofampkandfattyacidoxidation
‡A
CTRP5 ameliorates palmitate-induced apoptosis and insulin resistance through activation of AMPK and fatty acid oxidation.
‡9
1
|
919
|
|
|
‡a
dangnyohwanimprovesglucoseutilizationandreducesinsulinresistancebyincreasingtheadipocytespecificglut4expressioninotsukalongevanstokushimafattyrats
‡A
Dangnyohwan improves glucose utilization and reduces insulin resistance by increasing the adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima Fatty rats.
‡9
1
|
919
|
|
|
‡a
dataonthedecreasedexpressionoffoxo1bymir1271inhepg2hepatocytes
‡A
Data on the decreased expression of FOXO1 by miR-1271 in HepG2 hepatocytes
‡9
1
|
919
|
|
|
‡a
dataontheeffectofmir15bontheexpressionofinsrinmurinec2c12myocytes
‡A
Data on the effect of miR-15b on the expression of INSR in murine C2C12 myocytes
‡9
1
|
919
|
|
|
‡a
dataontheexpressionandinsulinstimulatedphosphorylationofirs1bymir96inl6glut4mycmyocytes
‡A
Data on the expression and insulin-stimulated phosphorylation of IRS-1 by miR-96 in L6-GLUT4myc myocytes
‡9
1
|
919
|
|
|
‡a
dataontheexpressionofpepckinhepg2hepatocytestransfectedwithmir195
‡A
Data on the expression of PEPCK in HepG2 hepatocytes transfected with miR-195.
‡9
1
|
919
|
|
|
‡a
datasetontheidentificationofdifferentiallyexpressedgenesbyannealingcontrol1basedpcrinmitochondrialdnadepletedmyocytes
‡A
Dataset on the identification of differentially expressed genes by annealing control primer-based PCR in mitochondrial DNA-depleted myocytes.
‡9
1
|
919
|
|
|
‡a
depletionofmitochondrialdnacausesimpairedglucoseutilizationandinsulinresistanceinl6glut4mycmyocytes
‡A
Depletion of mitochondrial DNA causes impaired glucose utilization and insulin resistance in L6 GLUT4myc myocytes.
‡9
1
|
919
|
|
|
‡a
depletionofmitochondrialdnaupregulatestheexpressionofmdr1geneviaanincreaseinmrnastability
‡A
Depletion of mitochondrial DNA up-regulates the expression of MDR1 gene via an increase in mRNA stability.
‡9
1
|
919
|
|
|
‡a
ehd2interactswiththeinsulinresponsiveglucosetransporterglut4inratadipocytesandmayparticipateininsulininducedglut4recruitment
‡A
EHD2 interacts with the insulin-responsive glucose transporter (GLUT4) in rat adipocytes and may participate in insulin-induced GLUT4 recruitment.
‡9
1
|
919
|
|
|
‡a
ets2isinvolvedintranscriptionalregulationofc1qtnfrelatedprotein5inmusclecells
‡A
Ets-2 is involved in transcriptional regulation of C1qTNF-related protein 5 in muscle cells
‡9
1
|
919
|
|
|
‡a
exosomederivedmicrornasincancermetabolismpossibleimplicationsincancerdiagnosticsandtherapy
‡A
Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy.
‡9
1
|
919
|
|
|
‡a
geneticriskformetabolicsyndromeexaminationofcandidategenepolymorphismsrelatedtolipidmetabolisminjapanesepeople
‡A
Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people.
‡9
1
|
919
|
|
|
‡a
glucosetransportersandinsulinactionsomeinsightsintodiabetesmanagement
‡A
Glucose transporters and insulin action: some insights into diabetes management.
‡9
1
|
919
|
|
|
‡a
implicationsofmicrornasinthepathogenesisofdiabetes
‡A
Implications of microRNAs in the pathogenesis of diabetes.
‡9
1
|
919
|
|
|
‡a
inductionofmir29abysaturatedfattyacidsimpairsinsulinsignalingandglucoseuptakethroughtranslationalrepressionofirs1inmyocytes
‡A
Induction of miR-29a by saturated fatty acids impairs insulin signaling and glucose uptake through translational repression of IRS-1 in myocytes.
‡9
1
|
919
|
|
|
‡a
inductionofmir96bydietarysaturatedfattyacidsexacerbateshepaticinsulinresistancethroughthesuppressionofinsrandirs1
‡A
Induction of miR-96 by Dietary Saturated Fatty Acids Exacerbates Hepatic Insulin Resistance through the Suppression of INSR and IRS-1.
‡9
1
|
919
|
|
|
‡a
microrna126suppressesmesotheliomamalignancybytargetingirs1andinterferingwiththemitochondrialfunction
‡A
MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function
‡9
1
|
919
|
|
|
‡a
micrornaexpressionanalysisintheliverofhighfatdietinducedobesemice
‡A
MicroRNA expression analysis in the liver of high fat diet-induced obese mice
‡9
1
|
919
|
|
|
‡a
mir1271upregulatedbysaturatedfattyacidpalmitateprovokesimpairedinsulinsignalingbyrepressinginsrandirs1expressioninhepg2cells
‡A
MiR-1271 upregulated by saturated fatty acid palmitate provokes impaired insulin signaling by repressing INSR and IRS-1 expression in HepG2 cells
‡9
1
|
919
|
|
|
‡a
mir965pinducedbypalmiticacidsuppressesthemyogenicdifferentiationofc2c12myoblastsbytargetingfhl1
‡A
MiR-96-5p Induced by Palmitic Acid Suppresses the Myogenic Differentiation of C2C12 Myoblasts by Targeting FHL1
‡9
1
|
919
|
|
|
‡a
modulationofglut4andglut1recyclingbyinsulininratadipocyteskineticanalysisbasedontheinvolvementofmultipleintracellularcompartments
‡A
Modulation of GLUT4 and GLUT1 recycling by insulin in rat adipocytes: kinetic analysis based on the involvement of multiple intracellular compartments.
‡9
1
|
919
|
|
|
‡a
nacetylated Alpha linkedacidicdipeptidaseexpressedinratadipocytesislocalizedintheinsulinresponsiveglucosetransporterglut4intracellularcompartmentsandinvolvedintheinsulinstimulatedglut4recruitment
‡A
N-Acetylated Alpha -linked acidic dipeptidase expressed in rat adipocytes is localized in the insulin-responsive glucose transporter (GLUT4) intracellular compartments and involved in the insulin-stimulated GLUT4 recruitment.
‡9
1
|
919
|
|
|
‡a
obesityinducedmir15bislinkedcausallytothedevelopmentofinsulinresistancethroughtherepressionoftheinsulinreceptorinhepatocytes
‡A
Obesity-induced miR-15b is linked causally to the development of insulin resistance through the repression of the insulin receptor in hepatocytes.
‡9
1
|
919
|
|
|
‡a
proteomicanalysisofcellularchangeinvolvedinmitochondriatonucleuscommunicationinl6glut4mycmyocytes
‡A
Proteomic analysis of cellular change involved in mitochondria-to-nucleus communication in L6 GLUT4myc myocytes
‡9
1
|
919
|
|
|
‡a
regulationofthetranscriptionalactivationofctrp3inchondrocytesby100jun
‡A
Regulation of the transcriptional activation of CTRP3 in chondrocytes by c-Jun.
‡9
1
|
919
|
|
|
‡a
saturatedfattyacidinducedmir195impairsinsulinsignalingandglycogenmetabolisminhepg2cells
‡A
Saturated fatty acid-induced miR-195 impairs insulin signaling and glycogen metabolism in HepG2 cells.
‡9
1
|
919
|
|
|
‡a
saturatedfattyacidsinducedmir4245paggravatesinsulinresistanceviatargetinginsulinreceptorinhepatocytes
‡A
Saturated fatty acids-induced miR-424-5p aggravates insulin resistance via targeting insulin receptor in hepatocytes
‡9
1
|
919
|
|
|
‡a
sfrp2isatranscriptionaltargetofsrebp1inmousechondrogeniccells
‡A
Sfrp2 is a transcriptional target of SREBP-1 in mouse chondrogenic cells.
‡9
1
|
919
|
|
|
‡a
hepatocyteglucose6phosphatasesubcomponentt3itsrelationshiptoglut2
‡A
The hepatocyte glucose-6-phosphatase subcomponent T3: its relationship to GLUT2.
‡9
1
|
919
|
|
|
‡a
inductionofmicrornatargetingirs1isinvolvedinthedevelopmentofinsulinresistanceunderconditionsofmitochondrialdysfunctioninhepatocytes
‡A
The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes
‡9
1
|
919
|
|
|
‡a
inductionofmir96bymitochondrialdysfunctioncausesimpairedglycogensynthesisthroughtranslationalrepressionofirs1inskhep1cells
‡A
The induction of miR-96 by mitochondrial dysfunction causes impaired glycogen synthesis through translational repression of IRS-1 in SK-Hep1 cells.
‡9
1
|
919
|
|
|
‡a
datafordifferentiallyexpressedmicrornasinsaturatedfattyacidpalmitatetreatedhepg2cells
‡A
Data for differentially expressed microRNAs in saturated fatty acid palmitate-treated HepG2 cells
‡9
1
|
996
|
|
|
‡2
ISNI|0000000468300843
|
996
|
|
|
‡2
ISNI|0000000504594747
|
996
|
|
|
‡2
ISNI|0000000468475619
|
996
|
|
|
‡2
ISNI|0000000041446747
|
996
|
|
|
‡2
ISNI|0000000513635651
|
996
|
|
|
‡2
ISNI|0000000465036768
|
996
|
|
|
‡2
ISNI|0000000464623899
|
996
|
|
|
‡2
ISNI|0000000055061311
|
996
|
|
|
‡2
ISNI|0000000467787127
|
996
|
|
|
‡2
ISNI|0000000491675678
|
996
|
|
|
‡2
ISNI|0000000460963909
|
996
|
|
|
‡2
ISNI|0000000479356455
|
996
|
|
|
‡2
DNB|125181946X
|
996
|
|
|
‡2
NII|DA15571796
|
996
|
|
|
‡2
ISNI|0000000492137126
|
996
|
|
|
‡2
BIBSYS|97012034
|
996
|
|
|
‡2
ISNI|0000000062634173
|
996
|
|
|
‡2
ISNI|0000000465071686
|
996
|
|
|
‡2
DNB|1268138940
|
996
|
|
|
‡2
ISNI|0000000467782334
|
996
|
|
|
‡2
ISNI|0000000491656530
|
996
|
|
|
‡2
JPG|500724267
|
996
|
|
|
‡2
DNB|136706150
|
996
|
|
|
‡2
NUKAT|n 97018472
|
996
|
|
|
‡2
LC|n 80002796
|
996
|
|
|
‡2
ISNI|000000047589730X
|
996
|
|
|
‡2
NUKAT|n 2021009374
|
996
|
|
|
‡2
ISNI|0000000493084847
|
996
|
|
|
‡2
ISNI|0000000467782123
|
996
|
|
|
‡2
NII|DA10965728
|
996
|
|
|
‡2
DNB|1153502186
|
996
|
|
|
‡2
LC|no2017131148
|
996
|
|
|
‡2
ISNI|0000000459467297
|
996
|
|
|
‡2
ISNI|0000000492195828
|
996
|
|
|
‡2
ISNI|0000000463655397
|
996
|
|
|
‡2
BNF|16549532
|
996
|
|
|
‡2
ISNI|0000000076990611
|
996
|
|
|
‡2
SUDOC|075204827
|
996
|
|
|
‡2
ISNI|0000000493220861
|
996
|
|
|
‡2
DNB|113496479X
|
996
|
|
|
‡2
ISNI|0000000505543220
|
996
|
|
|
‡2
ISNI|0000000477167407
|
996
|
|
|
‡2
ISNI|0000000463275482
|
996
|
|
|
‡2
ISNI|000000046834749X
|
996
|
|
|
‡2
BLBNB|000296303
|
996
|
|
|
‡2
BIBSYS|4052738
|
996
|
|
|
‡2
PLWABN|9811785349105606
|
996
|
|
|
‡2
LC|n 79102084
|
996
|
|
|
‡2
ISNI|0000000464376728
|
996
|
|
|
‡2
ISNI|0000000459355033
|
996
|
|
|
‡2
DBC|87097991346699
|
996
|
|
|
‡2
ISNI|0000000491971223
|
996
|
|
|
‡2
LC|nb2009015797
|
996
|
|
|
‡2
ISNI|0000000492164247
|
996
|
|
|
‡2
ISNI|0000000478401760
|
996
|
|
|
‡2
ISNI|0000000477195037
|
996
|
|
|
‡2
ISNI|0000000505786011
|
996
|
|
|
‡2
ISNI|0000000493993880
|
996
|
|
|
‡2
LC|n 2019184385
|
996
|
|
|
‡2
ISNI|0000000461031249
|
996
|
|
|
‡2
ISNI|000000046795137X
|
996
|
|
|
‡2
ISNI|0000000503872530
|
996
|
|
|
‡2
LC|nr 93049690
|
996
|
|
|
‡2
ISNI|0000000472495102
|
996
|
|
|
‡2
ISNI|0000000468069047
|
996
|
|
|
‡2
CAOONL|ncf10039232
|
996
|
|
|
‡2
ISNI|0000000063535564
|
996
|
|
|
‡2
ISNI|0000000493993223
|
996
|
|
|
‡2
LC|n 83003857
|
996
|
|
|
‡2
ISNI|0000000492320887
|
996
|
|
|
‡2
BNF|17085758
|
996
|
|
|
‡2
ISNI|0000000492339051
|
996
|
|
|
‡2
ISNI|000000005284509X
|
996
|
|
|
‡2
J9U|987007327546705171
|
996
|
|
|
‡2
ISNI|0000000044982270
|
996
|
|
|
‡2
RERO|A003507522
|
996
|
|
|
‡2
ISNI|0000000460923827
|
996
|
|
|
‡2
ISNI|0000000459777025
|
996
|
|
|
‡2
ISNI|0000000492322997
|
996
|
|
|
‡2
NTA|274156792
|
996
|
|
|
‡2
NTA|107914077
|
996
|
|
|
‡2
ISNI|0000000459885763
|
996
|
|
|
‡2
ISNI|0000000479336032
|
996
|
|
|
‡2
J9U|987007392805005171
|
996
|
|
|
‡2
CYT|AC000618788
|
996
|
|
|
‡2
LC|n 82251650
|
996
|
|
|
‡2
LC|no2022050085
|
996
|
|
|
‡2
ISNI|0000000459421432
|
996
|
|
|
‡2
ISNI|000000046845130X
|
996
|
|
|
‡2
ISNI|0000000493996942
|
996
|
|
|
‡2
LC|nr2001023492
|
996
|
|
|
‡2
BNF|17014816
|
996
|
|
|
‡2
ISNI|0000000045888454
|
996
|
|
|
‡2
ISNI|0000000479110543
|
996
|
|
|
‡2
ISNI|0000000493993354
|
996
|
|
|
‡2
LC|no2005098991
|
996
|
|
|
‡2
ISNI|0000000479110762
|
996
|
|
|
‡2
ISNI|0000000492103161
|
996
|
|
|
‡2
LC|no2010031552
|
996
|
|
|
‡2
N6I|vtls000078541
|
996
|
|
|
‡2
LC|no 95060537
|
996
|
|
|
‡2
ISNI|0000000491932953
|
996
|
|
|
‡2
RERO|A013981325
|
996
|
|
|
‡2
NSK|000344553
|
996
|
|
|
‡2
ISNI|0000000460715008
|
996
|
|
|
‡2
SUDOC|085856843
|
996
|
|
|
‡2
ISNI|000000050393894X
|
996
|
|
|
‡2
BNF|17942714
|
996
|
|
|
‡2
ISNI|0000000459426575
|
996
|
|
|
‡2
ISNI|0000000112508096
|
996
|
|
|
‡2
CAOONL|ncf13696593
|
996
|
|
|
‡2
LC|n 79074342
|
996
|
|
|
‡2
ISNI|0000000064184815
|
996
|
|
|
‡2
ISNI|0000000460720704
|
996
|
|
|
‡2
NII|DA08906409
|
996
|
|
|
‡2
J9U|987007398549905171
|
996
|
|
|
‡2
PLWABN|9812076410605606
|
996
|
|
|
‡2
LC|n 80148176
|
996
|
|
|
‡2
ISNI|0000000493992247
|
996
|
|
|
‡2
ISNI|0000000476229338
|
996
|
|
|
‡2
NTA|304102148
|
996
|
|
|
‡2
ISNI|0000000492136959
|
996
|
|
|
‡2
LC|no 94022778
|
996
|
|
|
‡2
ISNI|0000000072293413
|
996
|
|
|
‡2
DNB|170823881
|
996
|
|
|
‡2
ISNI|0000000512524845
|
996
|
|
|
‡2
ISNI|0000000463356223
|
996
|
|
|
‡2
NII|DA05877144
|
996
|
|
|
‡2
ISNI|0000000467607501
|
996
|
|
|
‡2
DNB|1026039525
|
996
|
|
|
‡2
LC|n 2007043502
|
996
|
|
|
‡2
ISNI|0000000479336382
|
996
|
|
|
‡2
ISNI|0000000464697900
|
996
|
|
|
‡2
LC|n 2024006578
|
996
|
|
|
‡2
ISNI|0000000063240379
|
996
|
|
|
‡2
ISNI|0000000478899538
|
996
|
|
|
‡2
ISNI|0000000491675723
|
996
|
|
|
‡2
ISNI|0000000468193179
|
996
|
|
|
‡2
LC|nb2011001505
|
996
|
|
|
‡2
SZ|1268138940
|
996
|
|
|
‡2
LC|no2023069189
|
996
|
|
|
‡2
ISNI|0000000505350330
|
996
|
|
|
‡2
ISNI|000000004231560X
|
996
|
|
|
‡2
DNB|170980103
|
996
|
|
|
‡2
ISNI|0000000081347380
|
996
|
|
|
‡2
BNF|12367865
|
996
|
|
|
‡2
LC|no2008166554
|
996
|
|
|
‡2
ISNI|0000000463408708
|
996
|
|
|
‡2
ISNI|0000000493991631
|
996
|
|
|
‡2
NSK|000356851
|
996
|
|
|
‡2
ISNI|0000000512790035
|
996
|
|
|
‡2
BNF|16922328
|
996
|
|
|
‡2
SUDOC|188697039
|
996
|
|
|
‡2
ISNI|0000000027329499
|
996
|
|
|
‡2
BIBSYS|1615358756400
|
996
|
|
|
‡2
ISNI|0000000492135585
|
996
|
|
|
‡2
ISNI|0000000493991105
|
996
|
|
|
‡2
DNB|1035819716
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
998
|
|
|
‡a
Wan, Lee
‡2
RERO|A028751219
‡3
exact name
|